Protogenix is developing a novel platform for protein production to replace the mammalian system.
Protogenix, Inc has raised $250K in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Protogenix, Inc is headquartered in Ithaca, United States.
Protogenix is developing a novel platform for protein production to replace the mammalian system.
Protogenix, Inc is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Protogenix, Inc — Funding & Investors." VCBacked, February 13, 2026, https://www.vcbacked.co/company/protogenix-inc. Accessed July 19, 2026.
VCBacked. (2026). Protogenix, Inc — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/protogenix-inc
{{cite web |title=Protogenix, Inc — Funding & Investors |url=https://www.vcbacked.co/company/protogenix-inc |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated